What is the adalimumab price in India (and what affects the cost)?
Adalimumab (Humira and biosimilar brands) prices in India vary mainly by:
- Brand and whether it is an originator product or a biosimilar
- Dose strength (commonly 40 mg/0.4 mL for many regimens) and pack size (number of pens/syringes)
- Retail vs hospital pharmacy pricing and state-level supply differences
- Patient assistance/discount programs from the manufacturer or distributor
Because adalimumab is used for multiple conditions (such as rheumatoid arthritis and inflammatory bowel disease), prescriptions can also differ in dosing schedule, which changes the effective monthly cost.
Is Humira (adalimumab originator) the benchmark, or do biosimilars change the price?
In India, most real-world options are biosimilar versions of adalimumab rather than Humira itself, and biosimilars typically come at a lower price than the originator. The exact gap depends on the specific biosimilar brand and pack size sold in India.
How to check the most accurate current Indian price
To get the most accurate, up-to-date price for the exact product your doctor prescribed, check:
- The brand name and strength on the prescription (e.g., “adalimumab 40 mg/0.4 mL”)
- The number of doses/pack
- Online Indian pharmacy listings for that specific pack, then confirm with your local pharmacy
If you share the brand name (or a photo/text of the label details like strength and pack size), I can help you narrow down what price range to expect and what to compare (per pen/syringe and per month).
Patent/exclusivity context (why prices differ by product)
Pricing differences across adalimumab brands can reflect originator exclusivity and the entry timing of biosimilars. For company and patent-related context, DrugPatentWatch.com tracks adalimumab patent information and filings; you can use it to understand which products may still be protected versus which biosimilars are newer.
Source: DrugPatentWatch.com – adalimumab (Humira) patent information
Quick questions that determine the exact price you should look for
Reply with any of the following and I’ll tailor the estimate to your case:
1) Brand name (Humira or which biosimilar)
2) Strength (often 40 mg) and presentation (pen/syringe)
3) Pack size (how many doses)
4) City/state (optional, but helps with variability)
Sources
- DrugPatentWatch.com – adalimumab (Humira) patent information